These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8765911)

  • 1. [Pulmonary lymphangioleiomyomatosis: empiric treatment of controlled trial?].
    Orehek J
    Rev Mal Respir; 1996 Jul; 13(3):199-202. PubMed ID: 8765911
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphangioleiomyomatosis.
    Kitaichi M; Izumi T
    Curr Opin Pulm Med; 1995 Sep; 1(5):417-24. PubMed ID: 9363104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchoscopic blood injection reducing lung volume in lymphangioleiomyomatosis.
    Kanoh S; Kobayashi H; Motoyoshi K
    Ann Thorac Surg; 2009 Apr; 87(4):1266-8. PubMed ID: 19324167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary lymphangioleiomyomatosis: a rare presentation.
    Bhat MA; Bhat GM
    Indian J Chest Dis Allied Sci; 2004; 46(3):209-11. PubMed ID: 15553210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of lymphangioleiomyomatosis].
    Zielonka TM; Piotrowska B; Kajfasz B; Mlekodaj S; Droszcz W
    Pneumonol Pol; 1990; 58(9-10):540-3. PubMed ID: 8614676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASSENT-3: implications for future trial design and clinical practice.
    Van de Werf F
    Eur Heart J; 2002 Jun; 23(12):911-2. PubMed ID: 12069439
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lymphangioleiomyomatosis].
    Minami H; Sakai S
    Ryoikibetsu Shokogun Shirizu; 1994; (4):188-91. PubMed ID: 8007126
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphangioleiomyomatosis: a rare cause of breathlessness.
    Vinodh BN; Sharma SK; Mukhopadhyay S; Gupta SD
    Indian J Chest Dis Allied Sci; 2004; 46(3):205-8. PubMed ID: 15553209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining heterogeneity in phase II trial designs may improve success in phase III.
    Tuma RS
    J Natl Cancer Inst; 2008 Feb; 100(3):164-6. PubMed ID: 18230788
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.
    Suman VJ; Dueck A; Sargent DJ
    Cancer Invest; 2008 Jun; 26(5):439-44. PubMed ID: 18568764
    [No Abstract]   [Full Text] [Related]  

  • 11. [Quantitative bibliographic analysis of French clinical research in the treatment of bronchopulmonary cancer].
    Lebeau B
    Rev Mal Respir; 1998 Apr; 15(2):185-9. PubMed ID: 9608989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment option(s) for pulmonary lymphangioleiomyomatosis: progress and current challenges.
    Krymskaya VP
    Am J Respir Cell Mol Biol; 2012 May; 46(5):563-5. PubMed ID: 22550272
    [No Abstract]   [Full Text] [Related]  

  • 13. [Unclear abdominal tumor in pulmonary lymphangioleiomyomatosis].
    Braunagel M; Schwarz F; Knösel T; Reiser MF; Graser A
    Radiologe; 2013 Jan; 53(1):61-4. PubMed ID: 23178789
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trial design in hepatocellular carcinoma.
    Johnson PJ; Billingham LJ
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):119-27. PubMed ID: 15757808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What can we learn from phase II adjuvant trials in melanoma?
    Keilholz U; Suciu S; Eggermont AM
    Br J Cancer; 2000 Jul; 83(1):6-7. PubMed ID: 10883660
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trial design in metastatic breast cancer: a commentary.
    Levine M
    Can J Oncol; 1995 Dec; 5 Suppl 1():40-2. PubMed ID: 8853523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II clinical trial design: methods in translational research from the Genitourinary Committee at the Eastern Cooperative Oncology Group.
    Gray R; Manola J; Saxman S; Wright J; Dutcher J; Atkins M; Carducci M; See W; Sweeney C; Liu G; Stein M; Dreicer R; Wilding G; DiPaola RS
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1966-9. PubMed ID: 16609005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulmonary lymphangioleiomyomatosis (clinical picture and therapeutic approach)].
    Chuchalin AG; Altunian MP; Bobkov EV
    Klin Med (Mosk); 1988 Feb; 66(2):55-9. PubMed ID: 3374053
    [No Abstract]   [Full Text] [Related]  

  • 19. Improving the design of phase II trials of cytostatic anticancer agents.
    Stone A; Wheeler C; Barge A
    Contemp Clin Trials; 2007 Feb; 28(2):138-45. PubMed ID: 16843736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphangioleiomyomatosis: A review.
    Hohman DW; Noghrehkar D; Ratnayake S
    Eur J Intern Med; 2008 Jul; 19(5):319-24. PubMed ID: 18549932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.